GeoVax Labs, Inc.

2.58 USD
+0.04 (+1.57%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

GeoVax Labs, Inc. stock is down -13.13% since 30 days ago. The next earnings date is May 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 41.38% of the previous 28 March’s closed higher than February.

About GeoVax Labs, Inc.

GeoVax Labs, Inc. develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV) and malaria.